Orkla ASA
F:OKL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Orkla ASA
F:OKL
|
NO |
|
Immunome Inc
NASDAQ:IMNM
|
US |
Wall St Price Targets
OKL Price Targets Summary
Orkla ASA
According to Wall Street analysts, the average 1-year price target for OKL is 10.2 EUR with a low forecast of 7.68 EUR and a high forecast of 13.46 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is OKL's stock price target?
Price Target
10.2
EUR
According to Wall Street analysts, the average 1-year price target for OKL is 10.2 EUR with a low forecast of 7.68 EUR and a high forecast of 13.46 EUR.
What is the Revenue forecast for Orkla ASA?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 5 years is 4%.
What is the Gross Profit forecast for Orkla ASA?
Projected CAGR
-29%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 3 years is -29%.
What is the Operating Income forecast for Orkla ASA?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 5 years is 6%.
What is the Pre-Tax Income forecast for Orkla ASA?
Projected CAGR
6%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 6%.
What is the Net Income forecast for Orkla ASA?
Projected CAGR
-6%
The compound annual growth rate for Net Income over the next 5 years is -6%.
